Skip to main content
. 2020 Jul 28;22(4):2810–2816. doi: 10.3892/mmr.2020.11375

Figure 1.

Figure 1.

5-Aza-dC increases miR-130a expression levels in Adr-treated acute myeloid leukemia cells. (A) The Cell Counting Kit-8 assay was performed to detect the viability of HL-60 cells. (B) Reverse transcription-quantitative PCR was performed to measure the expression levels of miR-130a in HL-60 cells. **P<0.001 vs. DMSO group treated with same Adr concentration. ##P<0.001 and #P<0.05 vs. 5-Aza-dC group treated with 0 µmol/l Adr. 5-Aza-dC, 5-aza-2′-deoxycytidine; miR, microRNA; Adr, Adriamycin; OD, optical density.